Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA)

Historical Holders from Q3 2021 to Q3 2025

Symbol
TNYA on Nasdaq
CUSIP
87990A106
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
180M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
31.6M
Holdings value
$19.3M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
88
Number of buys
45
Number of sells
-60
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
COLUMN GROUP III, LP 30.3% -5.31% $24.2M 49.3M 0% The Column Group Opportunity III, LP May 7, 2025
Woodline Partners LP 4.99% -25.9% $10.2M $3.48M 9M +52.1% Woodline Partners LP Jun 30, 2025
Empery Asset Management, LP 4.99% -49.7% $3.4M -$177K 8.3M -4.94% Empery Asset Management, LP Jun 30, 2025
Casdin Capital, LLC 4.3% $3.3M 6.73M Casdin Capital, LLC Mar 4, 2025
BlackRock, Inc. 1.7% -71.4% $1.12M -$1.05M 2.73M -48.4% BlackRock, Inc. Jun 30, 2025
JPMORGAN CHASE & CO 2.8% -52.9% $1.12M -$1.41M 2.28M -55.7% JPMORGAN CHASE & CO. Feb 28, 2025

Institutional Holders of Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 23.5K $38.1K +$10.5K $1.62 1
2025 Q2 31.6M $19.3M -$9.94M $0.61 88
2025 Q1 48.2M $27.5M +$1.98M $0.57 104
2024 Q4 43.6M $62.3M -$25.9M $1.43 82
2024 Q3 57.6M $111M +$67K $1.93 91
2024 Q2 56.9M $176M +$2.25M $3.10 93
2024 Q1 56M $293M +$50.7M $5.23 89
2023 Q4 18.4K $59.6K -$37.2K $3.24 1
2023 Q3 49.7M $127M -$3.32M $2.55 76
2023 Q2 47.7M $280M +$15.9M $5.87 79
2023 Q1 45M $128M -$2.29M $2.85 65
2022 Q4 47.1M $94.7M +$23M $2.01 66
2022 Q3 35.2M $102M -$12.3M $2.90 65
2022 Q2 37M $209M -$1.85M $5.63 45
2022 Q1 37.3M $440M +$23.6M $11.78 48
2021 Q4 35.4M $668M +$18.4M $18.95 46
2021 Q3 33.9M $693M +$693M $20.65 46